Literature DB >> 30065789

World Health Organization type B2 thymoma with an abundance of Hassall's corpuscles: A case report.

Li Gong1, Lu Sun2, Chenling Zhang3, Sanhua Wei4, Jun Chen5, Yazhuo Li2, Yanhong Li1, Wei Zhang1, Yongsheng Zhang6.   

Abstract

Hassall's corpuscles (HCs) are characteristic components of the medulla of the mammalian thymus and thymoma with an abundance of HCs is even more rare, with only five cases having been reported in the literature, to the best of our knowledge. Furthermore, their morphology usually resembles World Health Organization (WHO) type B2 or B3 thymoma. The biological behavior appears indolent and is rarely associated with myasthenia gravis. However, whether it is a separate entity or a variant of organotypical thymoma WHO B2 or B3 remains to be elucidated. The present case report reports a type B2 thymoma with a large presence of HCs from a 58-year-old Chinese woman, and investigates its histopathological characteristics, immunological features and biological behavior. Notably, the present case appeared biologically more aggressive compared with the cases reported previously. The aim of describing this rare case of thymoma with an abundance of HCs is so that it can be recognized and classified by pathologists.

Entities:  

Keywords:  Hassall's corpuscles; biological behavior; thymoma

Year:  2018        PMID: 30065789      PMCID: PMC6064780          DOI: 10.3892/ol.2018.8459

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  11 in total

Review 1.  Organization of thymic medullary epithelial heterogeneity: implications for mechanisms of epithelial differentiation.

Authors:  Andrew G Farr; James L Dooley; Matt Erickson
Journal:  Immunol Rev       Date:  2002-11       Impact factor: 12.988

2.  The human thymic microenvironment: thymic epithelium contains specific keratins associated with early and late stages of epidermal keratinocyte maturation.

Authors:  A J Laster; T Itoh; T J Palker; B F Haynes
Journal:  Differentiation       Date:  1986       Impact factor: 3.880

3.  Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?

Authors:  R Hubert Laeng; Tadaaki Eimoto; T-T Kuo; A Zettl; A Marx; Michael Moschopulos; Hisashi Tateyama; Kuniyasu Shimokawa
Journal:  Pathol Res Pract       Date:  2006-08-02       Impact factor: 3.250

Review 4.  The thymic microenvironment.

Authors:  R L Boyd; C L Tucek; D I Godfrey; D J Izon; T J Wilson; N J Davidson; A G Bean; H M Ladyman; M A Ritter; P Hugo
Journal:  Immunol Today       Date:  1993-09

5.  Spindle cell and mixed spindle/lymphocytic thymomas: an integrated clinicopathologic and immunohistochemical study of 81 cases.

Authors:  C C Pan; W Y Chen; H Chiang
Journal:  Am J Surg Pathol       Date:  2001-01       Impact factor: 6.394

6.  Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus.

Authors:  Norihiko Watanabe; Yi-Hong Wang; Heung Kyu Lee; Tomoki Ito; Yui-Hsi Wang; Wei Cao; Yong-Jun Liu
Journal:  Nature       Date:  2005-08-25       Impact factor: 49.962

Review 7.  From basic immunobiology to the upcoming WHO-classification of tumors of the thymus. The Second Conference on Biological and Clinical Aspects of Thymic Epithelial Tumors and related recent developments.

Authors:  A Marx; H K Müller-Hermelink
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

8.  Thymoma. Histologic subclassification is an independent prognostic factor.

Authors:  L Quintanilla-Martinez; E W Wilkins; N Choi; J Efird; E Hug; N L Harris
Journal:  Cancer       Date:  1994-07-15       Impact factor: 6.860

9.  Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.

Authors:  M Marino; H K Müller-Hermelink
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Polymorphism of Hassall's corpuscles in thymus of human fetuses.

Authors:  Adil Asghar; Yunus M Syed; Faruqi A Nafis
Journal:  Int J Appl Basic Med Res       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.